Showing results (141-150 of 246) with videos related to

Sort By:
Pageof 25
Cancer Research Communications|January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic TargetingJohn R Lozada, Andrew Elliott, Mark G Evans, et al.
JCO Precision Oncology|August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene AlterationsMihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
The Journal of Clinical Investigation|July 18, 2024
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancerSheng-Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.
Prostate Cancer and Prostatic Diseases|March 31, 2025
Racial variation in the advanced prostate cancer genomeEmily M Feng, Jenny Vo-Phamhi, Aishwarya N Subramanian, et al.
European Urology|November 6, 2020
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based TreatmentVicenç Ruiz de Porras, Xieng C Wang, Luis Palomero, et al.
NPJ Precision Oncology|August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumorsAaron S Mansfield, David S Hong, Christine L Hann, et al.
Nature Cancer|April 10, 2023
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancerMartin K Bakht, Yasutaka Yamada, Sheng-Yu Ku, et al.
Research Square|February 26, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Translational Oncology|November 15, 2020
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncologyShaham Beg, Rohan Bareja, Kentaro Ohara, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerBeatriz German, Katherine L Morel, Teia Noel, et al.
Pageof 25